Immunofluorescence measurement of C1 inactivator (alpha 2 neuraminoglycoprotein) activity of the surface of human carcinoma cells.
D000230:Adenocarcinoma / Q000276:immunology; D002288:Adenocarcinoma, Mucinous / Q000276:immunology; D000818:Animals; D001063:Appendiceal Neoplasms / Q000276:immunology; D001202:Ascitic Fluid / Q000276:immunology; D002277:Carcinoma / Q000276:immunology; D002462:Cell Membrane; D002478:Cells, Cultured; D003169:Complement Inactivator Proteins; D003537:Cystadenoma / Q000276:immunology; D005260:Female; D005455:Fluorescent Antibody Technique; D006023:Glycoproteins / Q000032:analysis*; D006801:Humans; D007122:Immunoelectrophoresis; D066298:In Vitro Techniques; D008214:Lymphocytes / Q000276:immunology*; D008722:Methods; D009369:Neoplasms / Q000276:immunology*; D009438:Neuraminic Acids / Q000032:analysis*; D010051:Ovarian Neoplasms / Q000276:immunology; D010996:Pleural Effusion / Q000276:immunology; D011817:Rabbits / Q000276:immunology; D013724:Teratoma / Q000276:immunology; D002583:Uterine Cervical Neoplasms / Q000276:immunology; D014594:Uterine Neoplasms / Q000276:immunology
D003169:Complement Inactivator Proteins; D006023:Glycoproteins; D009438:Neuraminic Acids